APO-Telmisartan/Amlodipine

APO-Telmisartan/Amlodipine

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-TE...
read more
Torisel

Torisel

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Epilim

Epilim

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Blooms The Chemist Fenofibrate

Blooms The Chemist Fenofibrate

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Camptosar

Camptosar

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Nuvigil (TB)

Nuvigil (TB)

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Vytorin (MK)

Vytorin (MK)

NOTICE: This Consumer Medicine Information (CMI) i...
read more
INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

PLYMOUTH MEETING, Pa., Dec. 7, 2020 /PRNewswire/ &...
read more
Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19

Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19

FOSTER CITY, Calif.–(BUSINESS WIRE)–Oc...
read more
US-British trio win Nobel Medicine Prize for Hepatitis C discovery

US-British trio win Nobel Medicine Prize for Hepatitis C discovery

Nobel Prize for medicine is awarded to two America...
read more